-
1
Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model
Published 2024-03-01Subjects: “…Hsd17b13…”
Get full text
Article -
2
Liver-specific inactivation of Cideb improves metabolic profiles and ameliorates steatohepatitis and fibrosis in animal models for MASH
Published 2025-04-01Subjects: Get full text
Article -
3
Advances in genetic variation in metabolism-related fatty liver disease
Published 2023-09-01Subjects: Get full text
Article -
4
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Published 2023-02-01Subjects: Get full text
Article -
5
Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis
Published 2021-12-01Subjects: “…HSD17B13 rs72613567:TA allelic variant…”
Get full text
Article -
6
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History
Published 2023-07-01Subjects: Get full text
Article -
7
The influence of host genetics on liver microbiome composition in patients with NAFLD
Published 2022-02-01Subjects: Get full text
Article -
8
Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort studyResearch in context
Published 2024-01-01Subjects: Get full text
Article -
9
ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF METABOLICALLY ASSOCIATED FATTY LIVER DISEASE (LITERATURE REVIEW)
Published 2024-06-01Subjects: “…genes pnpla3, tm6sf2, mboat7, hsd17b13, gckr, hfe, cp, ins, pparg, cyp11a, ar, enpp1, mttp.…”
Get full text
Article